STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Pyxis Oncology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/30/2025
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/30/2025
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/30/2025
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 30, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

Pyxis Oncology, Inc.

NASDAQ:PYXS

PYXS Rankings

PYXS Latest News

PYXS Latest SEC Filings

PYXS Stock Data

282.06M
46.58M
23.39%
33.73%
6.99%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON